Towards spatial frequency domain optical imaging of neurovascular coupling in a mouse model of Alzheimer's disease
暂无分享,去创建一个
Bruce J. Tromberg | Bernard Choi | Anthony J. Durkin | Soren D. Konecky | Alexander J. Lin | Tyler B. Rice | Kim N. Green
[1] Gian Luigi Lenzi,et al. Cerebrovascular Reactivity in Degenerative and Vascular Dementia: A Transcranial Doppler Study , 2007, European Neurology.
[2] David Hsiang,et al. Effects of motion on optical properties in the spatial frequency domain. , 2011, Journal of biomedical optics.
[3] Fabrizio Vernieri,et al. Cerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease , 2006, Stroke.
[4] Anthony J. Durkin,et al. Modulated imaging: quantitative analysis and tomography of turbid media in the spatial-frequency domain. , 2005, Optics letters.
[5] Anthony J. Durkin,et al. Quantitation and mapping of tissue optical properties using modulated imaging. , 2009, Journal of biomedical optics.
[6] E. Rüther,et al. Cerebrovascular reactivity to acetazolamide in (senile) dementia of Alzheimer's type: relationship to disease severity. , 1995, Dementia.
[7] Anthony J. Durkin,et al. Multispectral imaging of tissue absorption and scattering using spatial frequency domain imaging and a computed-tomography imaging spectrometer. , 2011, Journal of biomedical optics.
[8] Ann-Christine Ehlis,et al. Altered parietal brain oxygenation in Alzheimer's disease as assessed with near-infrared spectroscopy. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[9] F. LaFerla,et al. Alzheimer's disease. , 2010, The New England journal of medicine.
[10] Phillip B. Jones,et al. Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. , 2007, Brain : a journal of neurology.
[11] Sylvain Gioux,et al. Wavelength optimization for rapid chromophore mapping using spatial frequency domain imaging. , 2010, Journal of biomedical optics.
[12] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[13] T. Sera,et al. rCBF SPECT and the acetazolamide test in the evaluation of dementia. , 1998, Nuclear medicine review. Central & Eastern Europe.
[14] Ann-Christine Ehlis,et al. Reduced prefrontal oxygenation in Alzheimer disease during verbal fluency tasks. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[15] Bruce J. Tromberg,et al. Spatial Frequency Domain Imaging of Intrinsic Optical Property Contrast in a Mouse Model of Alzheimer’s Disease , 2011, Annals of Biomedical Engineering.
[16] Charles D. Smith,et al. Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease , 2009, Neurobiology of Aging.
[17] David J Mikulis,et al. Blood‐oxygen level dependent MRI measures of cerebrovascular reactivity using a controlled respiratory challenge: Reproducibility and gender differences , 2010, Journal of magnetic resonance imaging : JMRI.
[18] Marina Diomedi,et al. CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia , 2009, Journal of the Neurological Sciences.
[19] Jinsoo Uh,et al. Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease , 2012, Neurobiology of Aging.